PFE - 3 Biotech Stocks That Can Double Your Money in 2020
While the world of biotech has always been an interesting one, now's an especially exciting time to consider investing in the sector. There are many potential blockbuster drugs awaiting U.S. Food and Drug Administration (FDA) approval, with a number of treatments having already received a thumbs-up earlier this year.
For the companies that have been behind these breakthrough solutions, their financial prospects have never been better. Specifically, Amarin (NASDAQ: AMRN), Portola Pharmaceuticals (NASDAQ: PTLA), and Tandem Diabetes Care (NASDAQ: TNDM) are all likely to see their stock prices rise dramatically in the coming year due to treatments they are developing or have already developed.
Image source: Getty Images.